Pericardial Effusion With Tamponade in Lung Cancer Patients During Treatment With Nivolumab: A Report of Two Cases

Pericardial Effusion With Tamponade in Lung Cancer Patients During Treatment With Nivolumab: A Report of Two Cases

Background: Nivolumab is an immune checkpoint inhibitor (ICI) that has shown efficacy for treating non-small cell lung cancer and has become a standard therapy for previously treated non-small cell lung cancer. Moreover, immune-related adverse events of ICI therapy are well-known. Malignant pericard...

Full description

Bibliographic Details
Main Authors: Masahiro Yamasaki, Wakako Daido, Naomi Saito, Kunihiko Funaishi, Takenori Okada, Kazuma Kawamoto, Yu Matsumoto, Naoko Matsumoto, Masaya Taniwaki, Nobuyuki Ohashi, Noboru Hattori
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-01-01
Series:Frontiers in Oncology
Subjects:
pericardial effusion
tamponade
non-small cell lung cancer
nivolumab
pseudo-progression
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00004/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00004/full

Similar Items